Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of "Hold" From Brokerages
Teladoc Health, Inc. (NYSE:TDOC) Receives Consensus Recommendation of "Hold" From Brokerages
Shares of Teladoc Health, Inc. (NYSE:TDOC – Get Rating) have received a consensus recommendation of "Hold" from the thirty-five ratings firms that are covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, twenty-one have given a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month price target among analysts that have covered the stock in the last year is $54.59.
據MarketBeat Ratings報道,Teladoc Health,Inc.(紐約證券交易所代碼:TDOC-GET Rating)的股票已收到覆蓋該公司的35家評級公司的一致建議:持有。兩名投資分析師對該股的評級為賣出建議,21名分析師給出了持有建議,四名分析師對該公司發出了買入建議。在過去一年追蹤該股的分析師中,平均12個月目標價為54.59美元。
Several analysts have recently issued reports on TDOC shares. Berenberg Bank lowered shares of Teladoc Health from a "buy" rating to a "hold" rating and reduced their target price for the stock from $42.00 to $35.00 in a research note on Tuesday, August 2nd. Needham & Company LLC lowered shares of Teladoc Health from a "buy" rating to a "hold" rating in a research note on Thursday, July 28th. Piper Sandler reduced their price target on shares of Teladoc Health from $42.00 to $40.00 and set an "overweight" rating for the company in a research report on Thursday, July 28th. DA Davidson began coverage on shares of Teladoc Health in a research report on Friday, August 12th. They set a "buy" rating and a $45.00 price target for the company. Finally, Cowen lowered shares of Teladoc Health from an "outperform" rating to a "market perform" rating and reduced their price target for the company from $58.00 to $34.00 in a research report on Tuesday, August 2nd.
幾位分析師最近發佈了關於TDOC股票的報告。8月2日,貝倫貝格銀行在一份研究報告中將Teladoc Health的股票評級從買入下調至持有,並將該股的目標價從42.00美元下調至35.00美元。Needham&Company LLC在7月28日星期四的一份研究報告中將Teladoc Health的股票評級從“買入”下調至“持有”。派珀·桑德勒在7月28日週四的一份研究報告中將Teladoc Health的股票目標價從42.00美元下調至40.00美元,併為該公司設定了“增持”評級。達戴維森在8月12日星期五的一份研究報告中開始報道Teladoc Health的股票。他們為該公司設定了“買入”評級和45.00美元的目標價。最後,考恩在8月2日(星期二)的一份研究報告中將Teladoc Health的股票評級從“跑贏大盤”下調至“市場表現”,並將該公司的目標價從58.00美元下調至34.00美元。
Insider Buying and Selling at Teladoc Health
Teladoc Health的內部交易和銷售
In other Teladoc Health news, SVP Daniel Trencher sold 1,000 shares of the stock in a transaction that occurred on Monday, July 18th. The shares were sold at an average price of $41.12, for a total transaction of $41,120.00. Following the transaction, the senior vice president now directly owns 27,408 shares in the company, valued at $1,127,016.96. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Arnnon Geshuri sold 4,098 shares of the firm's stock in a transaction that occurred on Friday, August 26th. The shares were sold at an average price of $34.27, for a total value of $140,438.46. Following the transaction, the insider now owns 76,182 shares in the company, valued at $2,610,757.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Daniel Trencher sold 1,000 shares of the firm's stock in a transaction that occurred on Monday, July 18th. The stock was sold at an average price of $41.12, for a total transaction of $41,120.00. Following the completion of the transaction, the senior vice president now owns 27,408 shares in the company, valued at approximately $1,127,016.96. The disclosure for this sale can be found here. Insiders have sold 7,318 shares of company stock worth $255,321 over the last ninety days. Insiders own 1.55% of the company's stock.
在Teladoc Health的其他新聞中,高級副總裁Daniel·特倫徹在7月18日星期一的一筆交易中出售了1,000股該股。這些股票的平均價格為41.12美元,總成交金額為41,120.00美元。交易完成後,高級副總裁現在直接持有該公司27,408股股份,價值1,127,016.96美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過此超鏈接。在其他新聞方面,內部人士Arnnon Geshuri在8月26日星期五的一筆交易中出售了4098股該公司股票。這些股票的平均價格為34.27美元,總價值為140,438.46美元。交易完成後,這位內部人士現在擁有該公司76,182股,價值2,610,757.14美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可以通過美國證券交易委員會網站。此外,高級副總裁Daniel·特倫徹在7月18日星期一的一次交易中出售了1,000股該公司的股票。該股以41.12美元的平均價格出售,總成交金額為41120.00美元。交易完成後,高級副總裁現在擁有該公司27,408股股份,價值約1,127,016.96美元。關於這次銷售的披露可以找到這裏。在過去的90天裏,內部人士已經出售了7,318股公司股票,價值255,321美元。內部人士持有該公司1.55%的股份。
Institutional Inflows and Outflows
機構資金流入和流出
Teladoc Health Stock Performance
Teladoc Health股票表現
Shares of TDOC stock opened at $26.23 on Friday. Teladoc Health has a 12 month low of $25.95 and a 12 month high of $156.82. The company has a current ratio of 3.38, a quick ratio of 3.22 and a debt-to-equity ratio of 0.25. The firm has a market capitalization of $4.23 billion, a PE ratio of -0.43 and a beta of 0.86. The firm has a fifty day simple moving average of $33.75 and a two-hundred day simple moving average of $41.67.
上週五,TDOC股票開盤報26.23美元。Teladoc Health的12個月低點為25.95美元,12個月高位為156.82美元。該公司的流動比率為3.38,速動比率為3.22,債務權益比率為0.25。該公司市值為42.3億美元,市盈率為-0.43,貝塔係數為0.86。該公司的50日簡單移動均線為33.75美元,200日簡單移動均線為41.67美元。
Teladoc Health (NYSE:TDOC – Get Rating) last posted its earnings results on Wednesday, July 27th. The health services provider reported ($0.44) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.71) by $0.27. Teladoc Health had a negative net margin of 441.94% and a negative return on equity of 2.04%. The firm had revenue of $592.38 million during the quarter, compared to analyst estimates of $586.86 million. Analysts forecast that Teladoc Health will post -1.54 EPS for the current fiscal year.
Teladoc Health(紐約證券交易所代碼:TDOC-GET Rating)最近一次公佈收益結果是在7月27日星期三。這家醫療服務提供商公佈了本季度每股收益(EPS)(0.44美元),比普遍預期的(0.71美元)高出0.27美元。Teladoc Health的淨利潤率為負441.94%,淨資產回報率為負2.04%。該公司本季度營收為5.9238億美元,而分析師預期為5.8686億美元。分析師預測,Teladoc Health本財年的每股收益將達到1.54美元。
Teladoc Health Company Profile
Teladoc Health公司簡介
(Get Rating)
(獲取評級)
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions.
Teladoc Health,Inc.在美國和國際上提供虛擬醫療服務。該公司提供一系列服務和解決方案,涵蓋非緊急、間歇性、慢性和複雜的醫療狀況,包括糖尿病、高血壓、慢性腎臟疾病、癌症、充血性心力衰竭和精神健康狀況。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Teladoc Health (TDOC)
- Humana Proves Vertically Integrated Healthcare Works
- 2 Casino Stocks Worth Taking a Look At
- This Small-Cap Healthcare Name Is Outperforming Its Index
- What Cintas Can Teach Investors About This Bear Market?
- Blackberry Stock Declines As Results Come In Lukewarm Once Again
- 免費獲取StockNews.com關於Teladoc Health(TDOC)的研究報告
- Humana證明垂直整合的醫療保健工作
- 值得一看的2只賭場股票
- 這家小盤股醫療保健公司的表現好於其指數
- 關於這個熊市,Cintas能教給投資者什麼?
- 黑莓股價下跌,業績再次不温不火
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
接受Teladoc健康日報的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊接收對Teladoc Health和相關公司的最新新聞和分析師評級的每日簡要摘要。